Go Pro
→ CODE RED: AI Meltdown Imminent? (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agrify Corporation stock logo
AGFY
Agrify
$23.01
-2.0%		$22.05
$13.22
▼
$48.84
$46.09M9.9631,892 shs4,988 shs
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
$2.13
+0.2%		$2.18
$1.79
▼
$5.18
$44.70M0.44390,596 shs59,891 shs
RYTHM, Inc. stock logo
RYM
RYTHM
$22.14
-3.8%		$22.01
$14.00
▼
$53.65
$48.25M9.4414,935 shs1,913 shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.60
$4.00
$1.11
▼
$17.50
$15.17M0.162,868 shs1,975 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agrify Corporation stock logo
AGFY
Agrify
+0.82%+9.54%+3.16%-5.36%-40.42%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-0.93%-0.93%-2.75%-10.55%-31.83%
RYTHM, Inc. stock logo
RYM
RYTHM
-1.96%+10.20%+0.07%-15.99%-39.19%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
+1.41%+4.20%-15.69%+14.29%-72.31%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agrify Corporation stock logo
AGFY
Agrify
$23.01
-2.0%		$22.05
$13.22
▼
$48.84
$46.09M9.9631,892 shs4,988 shs
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
$2.13
+0.2%		$2.18
$1.79
▼
$5.18
$44.70M0.44390,596 shs59,891 shs
RYTHM, Inc. stock logo
RYM
RYTHM
$22.14
-3.8%		$22.01
$14.00
▼
$53.65
$48.25M9.4414,935 shs1,913 shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.60
$4.00
$1.11
▼
$17.50
$15.17M0.162,868 shs1,975 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agrify Corporation stock logo
AGFY
Agrify
+0.82%+9.54%+3.16%-5.36%-40.42%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-0.93%-0.93%-2.75%-10.55%-31.83%
RYTHM, Inc. stock logo
RYM
RYTHM
-1.96%+10.20%+0.07%-15.99%-39.19%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
+1.41%+4.20%-15.69%+14.29%-72.31%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agrify Corporation stock logo
AGFY
Agrify
0.00
N/AN/AN/A
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
2.00
Hold$6.00183.02% Upside
RYTHM, Inc. stock logo
RYM
RYTHM
1.00
SellN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ZIVO, RYM, AGFY, and GRCE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
RYTHM, Inc. stock logo
RYM
RYTHM
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/3/2026
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/17/2026
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agrify Corporation stock logo
AGFY
Agrify
$12.26M3.83N/AN/A$10.47 per share2.24
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
N/AN/AN/AN/A$3.99 per shareN/A
RYTHM, Inc. stock logo
RYM
RYTHM
$17.28M2.90N/AN/A$6.06 per share3.80
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$15.85K957.35N/AN/A($0.81) per share-4.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agrify Corporation stock logo
AGFY
Agrify
-$41.75M-$22.65N/AN/AN/A-424.11%-185.90%-72.67%N/A
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-$7.79M-$1.18N/AN/AN/AN/A-36.11%-34.39%11/12/2026 (Estimated)
RYTHM, Inc. stock logo
RYM
RYTHM
-$33.26M-$10.53N/AN/AN/A-6.20%-12.57%-2.60%N/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
-$7.78M-$1.40N/AN/AN/AN/AN/A-2,240.92%12/2/2026 (Estimated)

Latest ZIVO, RYM, AGFY, and GRCE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q1 2027
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
-$0.1293-$0.91-$0.7807-$0.91$0.40 millionN/A
8/4/2026Q2 2026
RYTHM, Inc. stock logo
RYM
RYTHM
N/A$0.09N/A$0.09N/A$23.02 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agrify Corporation stock logo
AGFY
Agrify
N/AN/AN/AN/AN/A
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
N/AN/AN/AN/AN/A
RYTHM, Inc. stock logo
RYM
RYTHM
N/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agrify Corporation stock logo
AGFY
Agrify
1.43
2.64
2.52
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
N/A
11.47
11.47
RYTHM, Inc. stock logo
RYM
RYTHM
N/A
0.59
0.56
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/A
0.17
0.17

Institutional Ownership

CompanyInstitutional Ownership
Agrify Corporation stock logo
AGFY
Agrify
5.98%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
6.08%
RYTHM, Inc. stock logo
RYM
RYTHM
5.98%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
12.83%

Insider Ownership

CompanyInsider Ownership
Agrify Corporation stock logo
AGFY
Agrify
2.16%
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
10.84%
RYTHM, Inc. stock logo
RYM
RYTHM
3.48%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
48.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agrify Corporation stock logo
AGFY
Agrify
1402.00 million1.96 millionNot Optionable
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
521.04 million18.76 millionN/A
RYTHM, Inc. stock logo
RYM
RYTHM
1412.18 million2.10 millionN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
104.22 million2.91 millionNot Optionable

Recent News About These Companies

ZIVO Bioscience (NASDAQ:ZIVO) Stock Price Passes Below 200 Day Moving Average - Here's Why
September 19, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31032241
Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 12, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260512411739/en/zivo-bioscience-inc.-announces-transition-to-otcid-marketplace/
Zivo Bioscience Inc. Wt
April 11, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/zivow
ZIVO Bioscience Provides Special Letter to Shareholders
March 27, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260327190358/en/ZIVO-Bioscience-Provides-Special-Letter-to-Shareholders/
Maxim Group Reaffirms Their Hold Rating on Zivo Bioscience (ZIVO)
December 15, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ZIVO/pressreleases/36474537/maxim-group-reaffirms-their-hold-rating-on-zivo-bioscience-zivo/
ZIVO Bioscience releases letter to shareholders
September 14, 2025  |  wattagnet.comW
ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
September 10, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250910182550/en/zivo-bioscience-ceo-letter-to-shareholders-highlights-progress-with-human-nutrition-and-animal-therapeutic-businesses/
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry
June 20, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250620564330/en/zivo-bioscience-and-leading-global-animal-health-company-to-advance-zivo%e2%80%99s-immune-enhancing-compounds-in-poultry/
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 7, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/university-delaware-study-identifies-optimal-215400486.html
University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 6, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250506414477/en/university-of-delaware-study-identifies-optimal-formulation-of-zivo%e2%80%99s-active-ingredients-for-further-testing-to-mitigate-avian-influenza-in-poultry/
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 6, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250206639313/en/zivo-bioscience-plans-new-study-with-university-of-delaware-to-combat-avian-influenza-in-poultry/
Zivo Bioscience issues new shares, raises $1.5 million
January 28, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/zivo-bioscience-issues-new-shares-raises-1-5-million/ar-AA1xZjTM
Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed
January 1, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/tuesdays-insider-activity-top-buys-and-sells-in-us-stocks-revealed-93CH-3793355
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 20, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241220941955/en/ZIVO-Bioscience-Reports-Preliminary-Efficacy-of-its-Proprietary-Active-Ingredients-in-the-Battle-Against-Avian-Influenza/
Regencell Bioscience Holdings Ltd RGC
February 1, 2024  |  morningstar.comM
ZIVO Bioscience Announces Uplisting to OTCQB Market
January 29, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/zivo-bioscience-announces-uplisting-otcqb-130000877.html?.tsrc=rss
Ideaya Biosciences
January 18, 2024  |  forbes.comhttps://www.forbes.com/companies/ideaya-biosciences/
Dare Bioscience Inc DARE
January 14, 2024  |  morningstar.comM
Zivo Bioscience Inc (ZIVO) USD0.001
November 11, 2023  |  hl.co.ukhttps://www.hl.co.uk/shares/shares-search-results/z/zivo-bioscience-inc-usd1.001/costs
Zivo Bioscience (ZIVO) Price Target Increased by 500.00% to 36.72
November 1, 2023  |  msn.comhttps://www.msn.com/en-us/money/markets/zivo-bioscience-zivo-price-target-increased-by-50000-to-3672/ar-AA1jflXo

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agrify stock logo

Agrify NASDAQ:AGFY

$23.01 -0.46 (-1.96%)
As of 09/23/2026

Agrify Corporation offers hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. It offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. The company also provides associated services comprising consulting, engineering, and construction. In addition, the company offers hydrocarbon, alcohol, solventless, post-processing, and lab equipment, as well as provides indoor farming solutions. In addition, it offers equipment and services in a contract and purchase order. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Troy, Michigan.

Grace Therapeutics stock logo

Grace Therapeutics NASDAQ:GRCE

$2.12 +0.01 (+0.24%)
As of 11:29 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Grace Therapeutics Inc. is a late-stage biopharma company advancing GTx-104, its novel injectable formulation of nimodipine which addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage. Grace Therapeutics Inc., formerly known as Acasti Pharma Inc., is based in Princeton, New Jersey.

RYTHM stock logo

RYTHM NASDAQ:RYM

$22.14 -0.87 (-3.78%)
As of 11:24 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.

ZIVO Bioscience stock logo

ZIVO Bioscience NASDAQ:ZIVO

$3.60 0.00 (0.00%)
As of 09/23/2026 12:57 PM Eastern

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas